Lead sponsor
Transposon Therapeutics, Inc.
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
84
Total enrollment
32
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
2
Trials by status
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTDStudy partner/caregiver requiredPh 2Completed42
A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)MMSE ≥18Ph 2Completed42